Korea To Examine Companies' R&D-Related Accounting For Transparency
Executive Summary
In a move to harmonize the pharma and biotech industry's accounting practices with global trends, South Korea’s financial authority will examine companies’ R&D cost-related accounting to check for possible ‘distortions’.